PPARG and cancer: Humanpancreatic cancer cells treated with relatively high concentrations of selectiveCOX-2 inhibitors showed an increased production and secretion of VEGF, whichwas inhibited by a pharmacological PPAR-γ antagonist and a dominant-negative PPAR-γ receptor [42].